Author:
Cinciripini Paul M.,Wetter David W.,Wang Jian,Yu Robert,Kypriotakis George,Kumar Tapsi,Robinson Jason D.,Cui Yong,Green Charles E.,Bergen Andrew W.,Kosten Thomas R.,Scherer Steven E.,Shete Sanjay
Abstract
AbstractDespite the large public health toll of smoking, genetic studies of smoking cessation have been limited with few discoveries of risk or protective loci. We investigated common and rare variant associations with success in quitting smoking using a cohort from 8 randomized controlled trials involving 2231 participants and a total of 10,020 common and 24,147 rare variants. We identified 14 novel markers including 6 mapping to genes previously related to psychiatric and substance use disorders, 4 of which were protective (CYP2B6 (rs1175607105), HTR3B (rs1413172952; rs1204720503), rs80210037 on chr15), and 2 of which were associated with reduced cessation (PARP15 (rs2173763), SCL18A2 (rs363222)). The others mapped to areas associated with cancer including FOXP1 (rs1288980) and ZEB1 (rs7349). Network analysis identified significant canonical pathways for the serotonin receptor signaling pathway, nicotine and bupropion metabolism, and several related to tumor suppression. Two novel markers (rs6749438; rs6718083) on chr2 are flanked by genes associated with regulation of bodyweight. The identification of novel loci in this study can provide new targets of pharmacotherapy and inform efforts to develop personalized treatments based on genetic profiles.
Publisher
Springer Science and Business Media LLC
Reference153 articles.
1. US Department of Health and Human Services. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health (2014).
2. Ambrose, J. A. & Barua, R. S. The pathophysiology of cigarette smoking and cardiovascular disease. An update. J. Am. Coll. Cardiol. 43(10), 1731–1737. https://doi.org/10.1016/j.jacc.2003.12.047 (2004).
3. Yanbaeva, D. G., Dentener, M. A., Creutzberg, E. C., Wesseling, G. & Wouters, E. F. M. Systemic effects of smoking. Chest. 131(5), 1557–1566. https://doi.org/10.1378/chest.06-2179 (2007).
4. World Health Organization. Global report on trends in prevalence of tobacco use 2000–2025. Accessed February 24 (2022).
5. US Department of Health and Human Services. Smoking Cessation: A Report of the Surgeon General. Washington (DC) (2020).